One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus

von van Asseldonk, Edwin J P
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2015)